Table 3.
Inter and intra group comparisons of Short Form-36
| Parameter | Group AC (n=19) | Group AC+CII (n=20) | p | |
|---|---|---|---|---|
| SF-36 Physical functioning | Pre-treatment | 75 (40–95) | 75 (25–95) | p>0.05 |
| Post-treatment | 85 (45–100) | 77.5 (35–100) | 0.610 | |
| p | 0.002** | 0.039* | ||
| SF-36 Physical role | Pre-treatment | 0 (0–100) | 0 (0–100) | 0.365 |
| Post-treatment | 0 (0–100) | 62.5 (0–100) | 0.599 | |
| p | 0.016* | 0.023* | ||
| SF-36 Emotional role | Pre-treatment | 0 (0–100) | 33.3 (0–100) | 0.027* |
| Post-treatment | 33.3 (0–100) | 66.6 (0–100) | 0.412 | |
| p | 0.008** | 0.048* | ||
| SF-36 Vitality | Pre-treatment | 65 (0–100) | 47.5 (5–85) | 0.243 |
| Post-treatment | 65 (0–100) | 42.5 (10–90) | 0.285 | |
| p | 0.617 | 0.196 | ||
| SF-36 Mental health | Pre-treatment | 56 (8–88) | 70 (16–80) | 0.481 |
| Post-treatment | 56 (16–84) | 66 (28–88) | 0.463 | |
| p | 0.356 | 0.703 | ||
| SF-36 Social role functioning | Pre-treatment | 100 (0–100) | 100 (0–100) | 0.722 |
| Post-treatment | 100 (62.5–100) | 100 (25–100) | 0.062 | |
| p | 0.031* | 0.172 | ||
| SF-36 Bodily pain | Pre-treatment | 51 (10–74) | 42 (10–72) | 0.462 |
| Post-treatment | 51 (10–100) | 52 (10–84) | 0.743 | |
| p | 0.520 | 0.016* | ||
| SF-36 General health | Pre-treatment | 67 (20–97) | 60 (15–80) | 0.339 |
| Post-treatment | 57 (10–97) | 62.5 (25–92) | 0.592 | |
| p | 0.171 | 0.116 |
Data presented as median (25–75%)
Group AC: Group Acetaminophen; Group AC + CII: Group Acetaminophen + Native Type II Collagen; SF-36: Short Form-36
*:
p<0.05
**:
p< 0.005